DrugPatentWatch Database Preview
Drugs in MeSH Category Central Nervous System Stimulants
» See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specgx Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 040436-002 | Jan 29, 2002 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Takeda Pharms Usa | VYVANSE | lisdexamfetamine dimesylate | TABLET, CHEWABLE;ORAL | 208510-004 | Jan 28, 2017 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Abbott | CYLERT | pemoline | TABLET;ORAL | 016832-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Sun Pharm Industries | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | TABLET;ORAL | 201231-002 | Sep 24, 2015 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Takeda Pharms Usa | VYVANSE | lisdexamfetamine dimesylate | TABLET, CHEWABLE;ORAL | 208510-002 | Jan 28, 2017 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |